Pfenex Inc.

Pfenex Inc.
Stock Exchange NYSE
EPS
$1.09
Market Cap
$230.91 M
Shares Outstanding
31.5 M
Public Float
30.77 M

Profile

Address
10790 Roselle Street
San Diego California 92121
United States
Employees -
Website http://www.pfenex.com
Updated 07/08/2019
Pfênex, Inc. is a clinical-stage biotechnology company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes biosimilars and vaccines. The company was founded on November 19, 2009 and is headquartered in San Diego, CA.

Financials

View All

Evert Schimmelpennink
President, CEO, Secretary & Director
Jason Grenfell-Gardner
Independent Director